The Xsphera ex vivo platform, invented at the Dana-Farber Cancer Institute, is a powerful integration of biology and cloud computing that accelerates drug development and guides precision medicine. Our proprietary process enables the simultaneous assessment of multiple therapeutics on a single patient-derived tumor specimen.
Ready to Learn More?
© 2022 Xsphera Biosciences
6 Tide Street
Boston, MA, 02210 — ALL RIGHTS RESERVED